FilingReader Intelligence
Jubilant Pharmova sells API business to subsidiary
July 24, 2025 at 07:14 PM UTC•By FilingReader AI
Jubilant Pharmova Limited announced shareholders approved a special resolution to sell and transfer its Active Pharmaceutical Ingredients (API) business to Jubilant Biosys Limited, a wholly-owned subsidiary.
The resolution passed with 99.9966% of votes in favor, with 124,557,198 valid votes cast from 101,083 shareholders, demonstrating strong support for the strategic restructuring.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:JUBLPHARMA•Bombay Stock Exchange
News Alerts
Get instant email alerts when JUBILANT PHARMOVA publishes news
Free account required • Unsubscribe anytime